Vascular response to drug-eluting stent with biodegradable vs. durable polymer - Optical coherence tomography substudy of the next

Circulation Journal

Volumn 78, Issue 10, 2014, Pages 2408-2414

  Kubo, Takashi ^a   Akasaka, Takashi ^a   Kozuma, Ken ^b   Kimura, Kazuo ^c   Fusazaki, Tetsuya ^d   Okura, Hiroyuki ^e   Shinke, Toshiro ^f   Ino, Yasushi ^a   Hasegawa, Takao ^g   Takashima, Hiroaki ^h   Takamisawa, Itaru ⁱ   Yamaguchi, Hiroshi ^j   Igarashi, Keiichi ^k   Kadota, Kazushige ^l   Tanabe, Kengo ^m   Nakagawa, Yoshihisa ⁿ   Muramatsu, Toshiya ^o   Morino, Yoshihiro ^d   Kimura, Takeshi ^p  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY HOSPITAL   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e KAWASAKI MEDICAL SCHOOL   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

^h AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

ⁱ Sakakibara Memorial Hospital   (Japan)

^j Tenyoukai Central Hospital   (Japan)

^k Hokkaido Social Insurance Hospital   (Japan)

^l KURASHIKI CENTRAL HOSPITAL   (Japan)

^m MITSUI MEMORIAL HOSPITAL   (Japan)

ⁿ TENRI HOSPITAL   (Japan)

^o SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^p KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Drug eluting stent; Optical coherence tomography; Percutaneous coronary intervention

Indexed keywords

BIODEGRADABLE POLYMER; DURABLE POLYMER; POLYMER; UNCLASSIFIED DRUG; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BIOLIMUS ELUTING STENT; BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; COMPARATIVE EFFECTIVENESS; CORONARY IMAGING CATHETER; DRUG ELUTING STENT; EVEROLIMUS ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; PROSPECTIVE STUDY; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BIODEGRADABLE IMPLANT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL;

ABSORBABLE IMPLANTS; AGED; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEOINTIMA; PERCUTANEOUS CORONARY INTERVENTION; SIROLIMUS;

EID: 84908255623     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0337     Document Type: Article

References (20)

1. Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, et al. Randomized comparison of everolimus-and paclitaxeleluting stents: 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol 2011; 58: 19-25.
2. Kimura T, Morimoto T, Natsuaki M, Shiomi H, Igarashi K, Kadota K, et al. Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET). Circulation 2012; 126: 1225-1236.
3. Wiemer M, Serruys PW, Miquel-Hebert K, Neumann FJ, Piek JJ, Grube E, et al. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT FIRST trial. Catheter Cardiovasc Interv 2010; 75: 997-1003.
4. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
5. Kubo T, Tanaka A, Kitabata H, Ino Y, Tanimoto T, Akasaka T. Application of optical coherence tomography in percutaneous coronary intervention. Circ J 2012; 76: 2076-2083.
6. Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H, et al. Examination of the in vivo mechanisms of late drugeluting stent thrombosis: Findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv 2012; 5: 12-20.
7. Natsuaki M, Kozuma K, Morimoto T, Kadota K, Muramatsu T, Nakagawa Y, et al. Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: A randomized, controlled, non-inferiority trial. J Am Coll Cardiol 2013; 62: 181-190.
8. Takano M, Murakami D, Yamamoto M, Kurihara O, Murai K, Inami T, et al. Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: Comparison with paclitaxel-eluting stents. Int J Cardiol 2013; 166: 181-186.
9. Kubo T, Akasaka T, Shite J, Suzuki T, Uemura S, Yu B, et al. OCT compared with IVUS in a coronary lesion assessment: The OPUSCLASS study. JACC Cardiovasc Imaging 2013; 6: 1095-1104.
10. Miyoshi N, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure: Six-month follow-up. Circ J 2010; 74: 903-908.
11. Byrne RA, Kastrati A, Massberg S, Wieczorek A, Laugwitz KL, Hadamitzky M, et al. Biodegradable polymer versus permanent polymer drug eluting stents and everolimus-versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial. J Am Coll Cardiol 2011; 58: 1325-1331.
12. Sakakibara T, Ishii H, Toriyama T, Aoyama T, Takahashi H, Kamoi D, et al. Sirolimus-eluting stent vs. everolimus-eluting stent for coronary intervention in patients on chronic hemodialysis. Circ J 2012; 76: 351-355.
13. Räber L, Magro M, Stefanini GG, Kalesan B, van Domburg RT, Onuma Y, et al. Very late coronary stent thrombosis of a newergeneration everolimus-eluting stent compared with early-generation drug-eluting stents: A prospective cohort study. Circulation 2012; 125: 1110-1121.
14. Choi HH, Kim JS, Yoon DH, Hong KS, Kim TH, Kim BK, et al. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: Comparison with sirolimus-eluting stent using optical coherence tomography. Int J Cardiovasc Imaging 2012; 28: 491-497.
15. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A, et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): A randomised non-inferiority trial. Lancet 2008; 372: 1163-1173.
16. Barlis P, Regar E, Serruys PW, Dimopoulos K, van der Giessen WJ, van Geuns RJ, et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: A LEADERS trial sub-study. Eur Heart J 2010; 31: 165-176.
17. Tada T, Kastrati A, Byrne RA, Schuster T, Cuni R, King LA, et al. Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography. Int J Cardiovasc Imaging 2014; 30: 495-504.
18. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008; 52: 333-342.
19. Kitabata H, Kubo T, Komukai K, Ishibashi K, Tanimoto T, Ino Y, et al. Effect of strut thickness on neointimal atherosclerotic change over an extended follow-up period (≥4 years) after bare-metal stent implantation: Intracoronary optical coherence tomography examination. Am Heart J 2012; 163: 608-616.
20. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Smits PC, et al. Clinical outcomes with bioabsorbable polymer-based versus durable polymer-based drug-eluting stents and bare metal stents: Evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 2014; 63: 299-307.